 Efficacy induction therapy cadaveric renal transplantation rabbit antithymocyte serum Minnesota globulin August July patients primary cadaveric kidney transplants RATS MALG induction phase quadruple immunosuppressive protocol Patient groups duration RATS MALG treatment time CyA induction equivalent Serum creatinine rejection year different Hematologic side effects dose reduction MALG patients adverse rejection results RATS group dosage reductions One-year patient survivals graft survival different groups Infectious complications MALG group significant factor deaths Monitoring lymphocyte subsets insignificant differences percent decrease cell population MALG RATS groups induction